ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.

Features

Auto Apply Resume Optimizer Cover Letter Optimizer Interview Prep

Company

Social Media

Need Help?

team@applyblast.com

Director, Pharmacovigilance at Beam Therapeutics - ApplyBlast

Director, Pharmacovigilance

Beam Therapeutics

4 months ago

4.1 on Glassdoor

Cambridge, MA

Onsite

Full Time

Director

0 applicants

View Job Listing

Apply to 100+ jobs

About this role

A Pharmacovigilance Expert at Beam Therapeutics provides strategic scientific and operational support for safety monitoring, signal management, and regulatory reporting across the company's precision genetic medicine portfolio. The role involves leading aggregate safety reports, managing vendor activities, ensuring inspection readiness, and collaborating cross-functionally to mitigate product risks throughout the drug lifecycle.

Responsibilities

Oversee day-to-day safety monitoring and clinical trial operations for assigned products
Lead development and review of aggregate safety reports including DSURs and PSURs
Manage vendor activities and ensure compliance with global regulatory requirements
Facilitate safety governance meetings and manage signal detection and assessment processes
Develop PV standard operating procedures and ensure departmental inspection readiness

Skills

Qualifications

PharmDMDBS in PharmacyBS in Nursing5+ years PV experience

About Beam Therapeutics

beamtx.com

Headquarters

Cambridge, Massachusetts, United States

Company Size

501-1000 employees

Founded

2017

View Profile

Beam Therapeutics is a clinical-stage biotechnology company based in Cambridge, MA, pioneering precision genetic medicines using its proprietary base editing platform to make precise single‑base DNA changes without creating double‑strand breaks. The company advances both in vivo and ex vivo programs across hematology, rare genetic diseases, and oncology, moving several candidates toward clinical development. Beam combines engineered editors, delivery technologies, and extensive safety profiling to create durable, potentially one‑time treatments and partners with academic and industry collaborators to accelerate translation.